This inventor holds 1 USPTO granted patent. Top assignee: Shenyang Pharmaceutical University. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Yong Cui: Innovator in Cancer Treatment
Introduction
Yong Cui is a prominent inventor based in Shenyang, China. He has made significant contributions to the field of cancer research through his innovative work. His research focuses on the VGSC β3 protein, which plays a crucial role in cancer prevention, treatment, and diagnostic detection.
Latest Patents
Yong Cui holds a patent titled "Target of VGSC β3 protein for prevention, treatment and diagnostic detection of cancers." This patent relates to inhibitors of the VGSC β3 protein and outlines methods for using this protein or its inhibitors to diagnose, prevent, and treat cancer. Additionally, it discusses screening antineoplastic agents using the VGSC β3 protein or its regulatory sequences.
Career Highlights
Yong Cui is affiliated with Shenyang Pharmaceutical University, where he conducts his research and contributes to the academic community. His work has garnered attention for its potential impact on cancer therapies and diagnostics.
Collaborations
Yong Cui collaborates with notable colleagues, including Yanfeng Liu and Jinghai Zhang. Their combined expertise enhances the research efforts in the field of cancer treatment.
Conclusion
Yong Cui's innovative work in cancer research exemplifies the importance of scientific advancements in improving healthcare outcomes. His contributions through patents and collaborations continue to pave the way for future developments in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile